We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Facet Biotech (MM) | NASDAQ:FACT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.01 | 0 | 00:00:00 |
Facet
Biotech Corp
|
Common
Stock
|
30303Q103
|
Seth
A. Klarman
The
Baupost Group, L.L.C.
10
St. James Avenue, Suite 1700
Boston,
Massachusetts 02116
(617)
210-8300
With
a copy to:
Gregory
D. Sheehan, Esq
Ropes
and Gray LLP
One
International Place
Boston,
Massachusetts 02110
|
April
8, 2010
|
*
|
The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover
page.
|
CUSIP NO. 30303Q103
|
13D
|
1.
|
NAME
OF REPORTING PERSON, S.S. OR I.R.S. IDENTIFICATION NO.OF ABOVE
PERSON
|
|
The
Baupost Group, L.L.C., 04-3402144
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
*
|
|
(a)
|
|
(b)
X
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS (SEE INSTRUCTIONS)
|
|
N/A
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|
The
Commonwealth of Massachusetts
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
|
7.
|
WITH
SOLE VOTING POWER
|
|
0
|
8.
|
WITH
SHARED VOTING POWER
|
|
1,500,000
|
9.
|
WITH
SOLE DISPOSITIVE POWER
|
|
0
|
10.
|
WITH
SHARED DISPOSITIVE POWER
|
|
1,500,000
|
|
1,500,000
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
|
|
¨
|
13.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
|
|
5.98%
|
|
IA
|
CUSIP NO. 30303Q103
|
13D
|
1.
|
NAME
OF REPORTING PERSON, S.S. OR I.R.S. IDENTIFICATION NO.OF ABOVE
PERSON
|
|
SAK
Corporation, 04-3334541
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
*
|
|
(a)
|
|
(b)
X
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS (SEE INSTRUCTIONS)
|
|
N/A
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|
The
Commonwealth of Massachusetts
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
|
7.
|
WITH
SOLE VOTING POWER
|
|
0
|
8.
|
WITH
SHARED VOTING POWER
|
|
1,500,000
|
9.
|
WITH
SOLE DISPOSITIVE POWER
|
|
0
|
10.
|
WITH
SHARED DISPOSITIVE POWER
|
|
1,500,000
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
1,500,000
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
¨
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
|
|
5.98%
|
14.
|
TYPE
OF REPORTING PERSON *
|
|
HC
|
|
CUSIP NO. 30303Q103
|
13D
|
1.
|
NAME
OF REPORTING PERSON, S.S.OR I.R.S. IDENTIFICATION NO.OF ABOVE
PERSON
|
|
Seth
A. Klarman
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
*
|
|
(a)
|
|
(b)
X
|
3.
|
SEC
USE ONLY
|
4.
|
SOURCE
OF FUNDS (SEE INSTRUCTIONS)
|
|
N/A
|
5.
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
¨
|
6.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
|
|
United
States of America
|
|
NUMBER
OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON:
|
7.
|
WITH
SOLE VOTING POWER
|
|
0
|
8.
|
WITH
SHARED VOTING POWER
|
|
1,500,000
|
9.
|
WITH
SOLE DISPOSITIVE POWER
|
|
0
|
10.
|
WITH
SHARED DISPOSITIVE POWER
|
|
1,500,000
|
11.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
|
|
1,500,000
|
12.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
|
|
¨
|
13.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW
(11)
|
|
5.98%
|
14.
|
TYPE
OF REPORTING PERSON *
|
CUSIP NO. 30303Q103
|
13D
|
(a)
|
The
responses to Items 7-13 of the cover pages of this Schedule 13D are
incorporated herein by reference.
|
(b)
|
The
responses to Items 7-13 of the cover pages of this Schedule 13D are
incorporated herein by reference.
|
(c)
|
The
trading dates, number of shares of Common Stock purchased or sold, and the
shares of Common Stock within the last 60 days, are set forth
below:
|
Name
|
Date
|
Price
Per Share
|
Number
of Shares
Purchased/(Sold)*
|
Baupost
|
4/8/2010
|
$26.96
|
(500,000)
|
|
|
|
|
(d)
|
No
other person has the right to receive or the power to direct the receipt
of dividends from, or the proceeds from the sale of, the shares of Common
Stock set forth above.
|
(e)
|
Not
Applicable.
|
CUSIP NO. 30303Q103
|
13D
|
1 Year Facet Biotech (MM) Chart |
1 Month Facet Biotech (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions